Onconova Announces Positive Data of Oral Rigosertib in Advanced Head and Neck Cancer
Wednesday, April 10, 2013
Oral rigosertib progresses to phase 2 clinical trial in squamous cell head and neck cancers.
Exelixis, Inc. Shows Mechanism of Action of Cabozantinib in a Prostate Cancer Bone Metastasis Model
Wednesday, April 10, 2013
Presentation of preclinical data provides insight into the mechanism of action of cabozantinib, with respect to its activity against prostate cancer tumors that have metastasized to the bone.
CvergenX, Inc. Partners with National Cancer Institute to Predict Radiation Therapy Success
Wednesday, April 10, 2013
Molecular signature assay could save costs and needless radiation therapy.
Seattle Genetics and Collaborators Highlight Multiple Ab-Drug Conjugate (ADC)
Wednesday, April 10, 2013
Presentations highlight preclinical data for novel programs and breakthroughs in research to develop highly stable linkers and more potent chemotypes.
OncoMed Presents New Data in Six Anti-Cancer Stem Cell Programs
Wednesday, April 10, 2013
Company highlights cancer drug progress.
Groundbreaking Clinical Trial Research on Genetic Basis of Children’s Health
Wednesday, April 10, 2013
Translational Research Institute at Inova utilizing joint solution to support unique clinical study of infants and their genomic profile.
New Gene Associated with Almost Doubled Alzheimer’s Risk in African-Americans
Wednesday, April 10, 2013
ABCA7, a minor gene variant in whites, is major player in African-Americans.
Bird Flu Mutation Study Offers Vaccine Clue
Tuesday, April 09, 2013
New findings to develop more effective vaccines against new strains of bird flu.
New System to Improve DNA Sequencing
Tuesday, April 09, 2013
A sensing system developed at Cambridge is being commercialised in the UK for use in rapid, low-cost DNA sequencing.
|
|
|
|
|
|
